Attached files

file filename
10-K - 10-K - AGENUS INCagen-10k_20201231.htm
EX-32.1 - EX-32.1 - AGENUS INCagen-ex321_9.htm
EX-31.2 - EX-31.2 - AGENUS INCagen-ex312_14.htm
EX-31.1 - EX-31.1 - AGENUS INCagen-ex311_13.htm
EX-23.1 - EX-23.1 - AGENUS INCagen-ex231_16.htm

 

EXHIBIT 21.1

SUBSIDIARIES OF AGENUS INC.

Antigenics LLC., a Delaware limited liability company and a wholly-owned subsidiary of Agenus Inc.

Agenus Royalty Fund, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Agenus Inc.

Agenus Switzerland Inc., a joint stock company organized under the laws of Switzerland formerly known as 4-Antibody AG, and a wholly-owned subsidiary of Agenus Inc.

Agenus West, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Agenus Inc.

Agenus UK Limited, a private limited company organized under the laws of England and Wales and a wholly-owned subsidiary of Agenus Inc.

AgenTus Therapeutics, Inc., a Delaware corporation and a majority-owned subsidiary of Agenus Inc.

AgenTus Therapeutics Limited, a private limited company organized under the laws of England and Wales and a wholly-owned subsidiary of AgenTus Therapeutics, Inc.

AgenTus Therapeutics SA, a company organized under the laws of Belgium and a wholly-owned subsidiary of AgenTus Therapeutics, Inc.